Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JD9Z
|
|||
| Drug Name |
PMID25656651-Compound-33b
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
PF MEDICAMENT [FR]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C30H33F2N7O2
|
|||
| Canonical SMILES |
CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=C4C=C(C=NC4=NN3)CC5=CC(=CC(=C5)F)F)NC6CCOCC6
|
|||
| InChI |
1S/C30H33F2N7O2/c1-38-6-8-39(9-7-38)24-2-3-25(27(17-24)34-23-4-10-41-11-5-23)30(40)35-29-26-15-20(18-33-28(26)36-37-29)12-19-13-21(31)16-22(32)14-19/h2-3,13-18,23,34H,4-12H2,1H3,(H2,33,35,36,37,40)
|
|||
| InChIKey |
HHXDZBJLUOYVEU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.